CHIP (particularly in DNMT3A, TET2, and ASXL1 genes, with VAFs > 10%) associates with a 36% risk increase for lung cancer across several cohorts, even when controlling for other confounders [44]. This evidence concerns the gene TET2 and lung carcinoma.